The disease is triggered by influenza viruses, which enter our body through droplets and then infect cells. Researchers from Switzerland and Japan have now investigated this virus in minute detail.

Most influenza viruses enter human or animal cells through specific pathways on the cells' surface. Researchers have now discovered that certain human flu viruses and avian flu viruses can also use a ...

Scientists have finally watched influenza viruses break into living human cells in real time, catching the microscopic invaders as they latch on, glide across the surface and slip inside. Instead of a ...

How flu viruses enter cells has been directly observed thanks to a new microscopy technique with the potential to revolutionize research on membrane biology, virus–host interactions and drug discovery ...

H5N1 avian influenza is highly pathogenic and has been devastating bird populations worldwide. It continues to do so, and is also moving into new animals, like skunks, bears, raccoons, cats, and dairy ...

Scientists have uncovered a surprising viral shortcut that turns moving cells into delivery vehicles for infection. Instead ...

Their discovery of how these viruses enter cells, and the subsequent development of the decoys, potentially sets the stage for new strategies to prevent and treat tick-borne encephalitis viruses, ...

Most influenza viruses enter human or animal cells through specific pathways on the cells' surface. Researchers at the University of Zurich have now discovered that certain human flu viruses and avian ...

Human noroviruses, GII.4 strains in particular, are the chief drivers of acute viral gastroenteritis around the world, a condition for which there are no vaccines or antivirals. Understanding how ...

For the first time, researchers have observed live and in high resolution how influenza (“flu”) viruses infect living cells. This was possible thanks to a new microscopy technique, developed at ETH ...

(Reuters) -Tiny viruses that only infect and kill bacteria can help treat deadly antibiotic-resistant bloodstream infections with Staphylococcus aureus, results from a mid-stage trial suggest.